Emerging surgical therapies in the treatment of pediatric epilepsy

Michael Karsy1, Jian Guan1, Katrina Ducis1

  • 11 Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, USA ; 2 Division of Neurosurgery, University of Vermont, Burlington, USA ; 3 Division of Pediatric Neurosurgery, Primary Children's Hospital, Salt Lake City, USA.

Insights

Minimally invasive epilepsy surgery and neurostimulation offer new hope for children with drug-resistant epilepsy, potentially improving outcomes and reducing the need for invasive procedures.

Area of Science:

  • Pediatric Neurology
  • Neurosurgery
  • Epilepsy Management

Background:

  • Drug-resistant epilepsy affects 1% of children, often leading to poor cognitive and developmental outcomes.
  • Current treatments may involve multiple invasive surgeries and diagnostic procedures.
  • New technologies are emerging to improve surgical management.

Purpose of the Study:

  • To review recent advancements in minimally invasive surgical techniques for pediatric drug-resistant epilepsy.
  • To discuss the applications and limitations of stereotactic electroencephalography (SEEG), MRI-guided laser interstitial thermal therapy (MRgLITT), and responsive neurostimulation (RNS).
  • To explore future research directions in pediatric epilepsy surgery.

Main Methods:

  • Review of current literature on minimally invasive surgical techniques and neurostimulation in pediatric epilepsy.
  • Discussion of the clinical applications, efficacy, and limitations of SEEG, MRgLITT, and RNS.
  • Analysis of the potential impact of these technologies on patient outcomes.

Main Results:

  • Minimally invasive techniques like SEEG and MRgLITT are transforming epilepsy diagnosis and treatment.
  • Neurostimulation, including RNS, presents new therapeutic avenues.
  • These advancements show potential to improve treatment efficacy and reduce surgical morbidity.

Conclusions:

  • Minimally invasive surgical options and novel neurostimulation paradigms hold significant promise for improving the care of children with drug-resistant epilepsy.
  • Further research is needed to optimize the application and long-term outcomes of these evolving technologies.
  • The integration of these techniques offers a pathway to better seizure control and quality of life for affected children.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.9K
Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
2.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K